|
Data Period (Except as noted, statistics reflect the most current day's trading) |
Daily |
Weekly |
Monthly |
Quarterly |
|
Open |
61.19 |
61.19 |
57.52 |
54.30 |
|
High |
61.42 |
61.42 |
61.43 |
61.43 |
|
Low |
60.59 |
60.59 |
57.49 |
53.44 |
|
Close |
61.29 |
61.29 |
61.29 |
61.29 |
|
Net change since last period end through current day |
0.85 |
0.85 |
4.98 |
7.65 |
|
Net change of previous completed period |
-0.46 |
1.40 |
1.03 |
-0.02 |
|
|
|
|
|
|
|
Volume
|
3,923↓ |
3,923↓ |
37,368↓ |
131,487↑ |
|
Total Volume of Component Issues
|
807,868↑ |
807,868↓ |
8,088,001↓ |
31,043,492↓ |
|
|
|
|
|
|
|
1 Year Price High |
61.43
|
61.43
|
61.43
|
61.43
 |
|
1 Year Price High Date |
3/12/10 |
3/12/10 |
3/15/10 |
3/15/10 |
|
1 Year Price Low |
43.16
|
43.16
|
43.06
|
43.06
|
|
1 Year Price Low Date |
4/23/09 |
4/24/09 |
3/31/09 |
3/31/09 |
|
|
|
|
|
|
|
Trend Pivot |
58.60 |
55.02 |
52.83 |
52.57 |
|
Current Trend |
Up
|
Up
|
Up
|
Up
|
|
|
Trend Gain/Loss as of Period End |
4.98 |
7.31 |
7.65 |
61.29 |
|
|
Trend Life (Periods) |
11 |
12 |
3 |
3 |
|
|
Trend Begin Date |
2/26/10 |
12/24/09 |
12/31/09 |
/0/ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
% Of Component Issues In Uptrends
|
76.92% |
88.46% |
84.62% |
73.08% |
|
|
Total Up Trends
|
20↓ |
23↕ |
22↑ |
19↑ |
|
|
|
New Up Trends
|
0 |
1 |
3 |
4 |
|
|
Total Down Trends
|
6↑ |
3↕ |
4↓ |
7↓ |
|
|
|
New Down Trends
|
2 |
1 |
1 |
1 |
|
|
|
|
|
|
|
|
Component Issues Traded |
26↕ |
26↕ |
26↕ |
26↕ |
|
|
% Of Component Issues Advancing |
61.54% |
61.54% |
84.62% |
84.62% |
|
|
Advancing Issues |
16↑ |
16↓ |
22↑ |
22↑ |
|
|
Declining Issues |
9↓ |
9↑ |
4↓ |
4↓ |
|
|
Unchanged Issues |
1↑ |
1↑ |
0↕ |
0↕ |
|
|
%
Advancing Volume |
78.35% |
78.35% |
75.54% |
89.09% |
|
|
Advancing Volume |
632,928↑ |
632,928↓ |
6,109,690↑ |
27,656,747↑ |
|
|
Declining Volume |
164,653↓ |
164,653↓ |
1,978,311↓ |
3,386,745↓ |
|
|
Unchanged Volume |
0↕ |
0↕ |
0↕ |
0↕ |
|
|
|
|
|
|
|
|
New Component 1 Year Highs |
5↑ |
5↓ |
14↑ |
15↑ |
|
|
New Component 1 Year Lows |
0↕ |
0↓ |
1↓ |
3↑ |
|
|
|
|
|
|
|
|
Component Issues Above/Below Period
Moving Average
|
|
|
|
|
|
|
|
% Above 200 Period Moving Average
|
84.62% |
76.92% |
92.31% |
100.00% |
|
|
|
|
Issues Above
|
22↓ |
20↕ |
24↕ |
26↕ |
|
|
|
|
Issues Below
|
4↑ |
6↕ |
2↕ |
0↕ |
|
|
|
% Above 50 Period Moving Average
|
76.92% |
88.46% |
76.92% |
84.62% |
|
|
|
|
Issues Above
|
20↓ |
23↕ |
20↑ |
22↕ |
|
|
|
|
Issues Below
|
6↑ |
3↕ |
6↓ |
4↕ |
|
|
|
% Above 30 Period Moving Average
|
80.77% |
84.62% |
73.08% |
84.62% |
|
|
|
|
Issues Above
|
21↓ |
22↑ |
19↑ |
22↑ |
|
|
|
|
Issues Below
|
5↑ |
4↓ |
7↓ |
4↓ |
|
|
|
% Above 18 Period Moving Average
|
76.92% |
88.46% |
84.62% |
73.08% |
|
|
|
|
Issues Above
|
20↓ |
23↕ |
22↕ |
19↑ |
|
|
|
|
Issues Below
|
6↑ |
3↕ |
4↕ |
7↓ |
|
|
|
% Above 9 Period Moving Average
|
73.08% |
80.77% |
80.77% |
80.77% |
|
|
|
|
Issues Above
|
19↑ |
21↓ |
21↑ |
21↑ |
|
|
|
|
Issues Below
|
7↓ |
5↑ |
5↓ |
5↓ |
|
|
|
% Above 4 Period Moving Average
|
53.85% |
76.92% |
80.77% |
88.46% |
|
|
|
|
Issues Above
|
14↓ |
20↓ |
21↑ |
23↑ |
|
|
|
|
Issues Below
|
12↑ |
6↑ |
5↓ |
3↓ |
|
|
|
|
|
|
|
|
|
Components |
Trend As Of Period End |
|
Data Period (Except as noted, statistics reflect the most current day's trading) |
Daily |
Weekly |
Monthly |
Quarterly |
|
SPDR S&P Biotech ETF (XBI)
|
2/26/10
|
12/24/09
|
12/31/09
|
/0/
|
|
OSI Pharmaceuticals Inc. (OSIP)
|
2/12/10
|
1/15/10
|
2/26/10
|
3/15/10
 |
|
Incyte Corporation (INCY)
|
2/26/10
|
5/29/09
|
8/31/09
|
9/30/09
|
|
Alkermes Inc. (ALKS)
|
2/26/10
|
12/4/09
|
1/29/10
|
12/31/07
|
|
Dendreon Corporation (DNDN)
|
2/11/10
|
1/8/10
|
4/30/09
|
6/30/09
|
|
Amylin Pharmaceuticals Inc. (AMLN)
|
2/26/10
|
11/27/09
|
12/31/09
|
3/31/08
|
|
Acorda Therapeutics Inc. (ACOR)
|
3/1/10
|
11/6/09
|
12/31/09
|
/0/
|
|
Regeneron Pharmaceuticals Inc. (REGN)
|
2/18/10
|
12/18/09
|
12/31/09
|
6/30/09
|
|
Seattle Genetics Inc. (SGEN)
|
2/24/10
|
2/12/10
|
3/15/10
|
9/29/06
|
|
BioMarin Pharmaceutical Inc. (BMRN)
|
3/1/10
|
11/20/09
|
1/29/10
|
3/15/10
|
|
United Therapeutics Corporation (UTHR)
|
3/15/10
|
11/20/09
|
12/31/09
|
6/30/09
|
|
Cubist Pharmaceuticals Inc. (CBST)
|
2/25/10
|
1/15/10
|
2/26/10
|
3/15/10
|
|
Cephalon Inc (CEPH)
|
2/9/10
|
12/11/09
|
2/26/10
|
3/15/10
|
|
Biogen Idec Inc (BIIB)
|
2/26/10
|
12/4/09
|
12/31/09
|
9/30/09
|
|
Celgene Corporation (CELG)
|
2/11/10
|
2/12/10
|
1/29/10
|
9/30/02
|
|
Genzyme General (GENZ)
|
2/11/10
|
1/8/10
|
11/28/08
|
12/31/08
|
|
Alexion Pharmaceuticals Inc. (ALXN)
|
2/16/10
|
2/12/10
|
5/29/09
|
3/31/06
|
|
Human Genome Sciences Inc. (HGSI)
|
2/11/10
|
3/5/10
|
7/31/09
|
9/30/09
|
|
Savient Pharmaceuticals Inc (SVNT)
|
2/24/10
|
3/5/10
|
12/31/09
|
6/30/09
|
|
Vertex Pharmaceuticals Incorporated (VRTX)
|
2/24/10
|
2/19/10
|
1/30/09
|
3/31/08
|
|
Amgen Inc (AMGN)
|
3/15/10
|
3/15/10
|
3/15/10
|
3/31/09
|
|
Gilead Sciences Inc. (GILD)
|
3/8/10
|
1/15/10
|
1/29/10
|
12/31/98
|
|
ONYX Pharmaceuticals Inc. (ONXX)
|
3/1/10
|
3/5/10
|
3/15/10
|
12/31/09
|
|
Myriad Genetics Inc. (MYGN)
|
2/26/10
|
3/12/10
|
7/31/09
|
3/31/06
|
|
Isis Pharmaceuticals Inc. (ISIS)
|
3/9/10
|
3/15/10
|
9/30/09
|
12/31/09
|
|
Exelixis Inc. (EXEL)
|
3/9/10
|
3/12/10
|
8/31/09
|
12/31/07
|
|
Medivation Inc. (MDVN)
|
3/3/10
|
3/5/10
|
3/15/10
|
3/15/10
|
|
|
